# Mogroside V

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/mogroside-v
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Luo han guo glycoside V, Monk fruit glycoside V, Siraitia grosvenorii glycoside V, MV, Mogrol 5-O-glucoside, Luo han guo saponin V, Grosvenorii Fructus glycoside V

## Overview

Mogroside V is the primary bioactive triterpene glycoside extracted from monk fruit (Luo Han Guo), comprising up to 1% of the fruit's dry weight. It exerts antioxidant, [anti-inflammatory](/ingredients/condition/inflammation), and potential anticancer effects primarily by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and suppressing NF-κB and COX-2 signaling pathways.

## Health Benefits

• May inhibit pancreatic cancer cell growth through apoptosis and angiogenesis inhibition (preclinical evidence only)
• Reduces [inflammation](/ingredients/condition/inflammation) by inhibiting COX-2 expression and NF-κB phosphorylation (in vitro studies)
• Supports cellular health through ROS scavenging and [mitochondrial function](/ingredients/condition/energy) (cell culture studies)
• Potential [neuroprotective effect](/ingredients/condition/cognitive)s in Parkinson's disease models (animal studies only)
• Modulates glucose and lipid [metabolism](/ingredients/condition/weight-management) via AMPK pathway activation (preclinical evidence)

## Mechanism of Action

Mogroside V suppresses inflammation by blocking IκB kinase phosphorylation, thereby preventing NF-κB nuclear translocation and downstream transcription of COX-2 and [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as IL-6 and TNF-α. Its [antioxidant activity](/ingredients/condition/antioxidant) stems from direct ROS scavenging and upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase, partially mediated through Nrf2/HO-1 pathway activation. In pancreatic cancer models, mogroside V promotes apoptosis via caspase-3 and caspase-9 activation while inhibiting VEGF-driven angiogenesis, reducing tumor vascularization in preclinical assays.

## Clinical Summary

The majority of evidence for mogroside V derives from in vitro cell line studies and rodent models, with no large-scale randomized controlled trials in humans published to date. In murine pancreatic cancer xenograft models, mogroside V administration reduced tumor volume by approximately 50% compared to controls, though translational relevance remains unestablished. [Anti-inflammatory](/ingredients/condition/inflammation) effects have been demonstrated in LPS-stimulated macrophage cultures and carrageenan-induced paw edema rat models at doses of 20–80 mg/kg, showing significant COX-2 and NF-κB suppression. Human clinical data are essentially absent for mogroside V in isolation, and extrapolating preclinical findings to therapeutic dosing in humans is premature.

## Nutritional Profile

Mogroside V is a cucurbitane-type triterpenoid glycoside (C60H102O29, MW ~1287.4 g/mol) and the principal sweet compound in monk fruit (Siraitia grosvenorii), responsible for approximately 200-300× the sweetness of sucrose. It is a non-caloric, non-glycemic compound with no significant macronutrient contribution (zero protein, fat, carbohydrate metabolizable energy). Key bioactive properties stem from its five glucose moieties attached to the mogrol aglycone backbone, which confer potent [antioxidant](/ingredients/condition/antioxidant) capacity (ORAC values significantly higher than vitamin C on a molar basis). Typical concentration in monk fruit extract standardized products ranges from 25-55% mogroside V by weight. Oral bioavailability is limited in intact form; gut microbiota hydrolyze mogroside V to mogrol and intermediate mogrosides (mogroside IIIE, mogroside IE) in the colon, and mogrol is the primary absorbed metabolite. Mogrol itself demonstrates significant [anti-inflammatory](/ingredients/condition/inflammation) and antioxidant bioactivity. No vitamins or minerals are present in the isolated compound.

## Dosage & Preparation

No clinically studied dosage ranges have been established for Mogroside V as human trials are absent. The compound is commercially available as a purified solid for research use and as a non-caloric sweetener, but therapeutic dosing lacks clinical validation. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Mogroside V and monk fruit extracts are generally recognized as safe (GRAS) by the FDA as food sweetening agents, with no significant adverse effects reported at typical dietary exposure levels. Because mogroside V may influence NF-κB and [inflammatory](/ingredients/condition/inflammation) signaling, theoretical interactions with immunosuppressant drugs such as corticosteroids or calcineurin inhibitors cannot be excluded, though no clinical interaction studies have been conducted. Pregnant and breastfeeding women should exercise caution due to the absence of controlled human safety data in these populations. Individuals with known hypersensitivity to Cucurbitaceae family plants, which includes monk fruit, should avoid supplementation.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses for Mogroside V were identified in the research dossier. All evidence comes from preclinical studies including in vitro experiments with PANC-1 pancreatic cancer cells and RAW264.7 macrophages, plus animal models for neuroprotection and metabolic effects.

## Historical & Cultural Context

Mogroside V is derived from Siraitia grosvenorii fruit, which has been used for centuries in Traditional Chinese Medicine as a natural sweetener and for respiratory ailments including cough and sore throat. The compound provides the fruit's intense sweetness, up to 300 times that of sucrose.

## Synergistic Combinations

Mogroside V pairs well with **curcumin (200-500 mg as standardized 95% curcuminoids)** because both converge on NF-κB inhibition and COX-2 suppression, amplifying [anti-inflammatory](/ingredients/condition/inflammation) effects through complementary upstream targeting (curcumin inhibits IKKβ while mogroside V reduces NF-κB phosphorylation directly). **Epigallocatechin gallate (EGCG, 200-400 mg from green tea extract)** synergizes by enhancing ROS scavenging across different cellular compartments — EGCG primarily neutralizes superoxide and hydroxyl radicals in the cytosol while mogrol (the active metabolite) supports [mitochondrial](/ingredients/condition/energy) membrane integrity. **Piperine (5-10 mg from black pepper extract)** enhances the bioavailability of co-administered polyphenols and may improve intestinal absorption of mogrol metabolites by inhibiting hepatic and intestinal glucuronidation (UGT enzymes). **Sulforaphane (10-30 mg from broccoli seed extract)** complements mogroside V's [antioxidant](/ingredients/condition/antioxidant) action by activating the Nrf2/ARE pathway, upregulating endogenous [Phase II detox](/ingredients/condition/detox)ification enzymes (glutathione S-transferase, NQO1), creating a dual exogenous-endogenous antioxidant defense strategy.

## Frequently Asked Questions

### Is mogroside V the same as monk fruit extract?

Mogroside V is the principal bioactive compound within monk fruit (Siraitia grosvenorii) extract, typically standardized to 20–50% mogroside V content in commercial supplements. Monk fruit extract contains a mixture of mogrosides (I through VI), but mogroside V is considered the most pharmacologically active and is responsible for the fruit's intense sweetness, estimated at 200–300 times that of sucrose.

### What is the studied dosage of mogroside V for anti-inflammatory effects?

Preclinical rodent studies demonstrating anti-inflammatory effects have used mogroside V doses ranging from 20 to 80 mg/kg body weight administered orally or intraperitoneally. No established human clinical dose exists, and commercial monk fruit supplements typically provide 100–500 mg of standardized extract per serving, delivering variable amounts of pure mogroside V depending on the concentration used.

### Can mogroside V help with blood sugar control?

Animal studies suggest mogroside V may improve insulin sensitivity and reduce fasting blood glucose in diabetic mouse models, partly by inhibiting α-glucosidase activity and reducing oxidative stress in pancreatic beta cells. However, these findings are derived exclusively from rodent models, and no peer-reviewed human clinical trials have confirmed glycemic benefits of isolated mogroside V supplementation to date.

### Does mogroside V have any proven anticancer effects in humans?

There are currently no published human clinical trials demonstrating anticancer effects of mogroside V. Existing evidence is limited to in vitro studies showing apoptosis induction in PANC-1 pancreatic cancer cell lines via caspase-3/9 activation, and mouse xenograft models showing roughly 50% tumor volume reduction. These results are hypothesis-generating but cannot be extrapolated to human cancer treatment.

### Is mogroside V safe for people with diabetes taking metformin?

No direct drug interaction studies between mogroside V and metformin have been published. Because mogroside V may independently influence blood glucose through alpha-glucosidase inhibition and insulin sensitization pathways in animal models, concurrent use could theoretically produce additive hypoglycemic effects, warranting blood glucose monitoring. Anyone with diabetes considering mogroside V supplementation should consult their healthcare provider before use.

### What is the difference between mogroside V and other mogrosides in monk fruit?

Mogroside V is the most abundant and potent bioactive compound in monk fruit, comprising 40–50% of the mogrosides present. While monk fruit contains other mogrosides (such as mogroside I, II, III, and IV), mogroside V demonstrates the strongest antioxidant and anti-inflammatory activity in laboratory studies. Most commercial monk fruit extracts are standardized to mogroside V content because of its superior bioactivity and stability profile.

### How much mogroside V is actually in monk fruit supplements, and does the dose vary?

Mogroside V content in monk fruit supplements typically ranges from 40–98% depending on extraction and concentration methods, with most products standardized to 50% or higher purity. A standard serving of monk fruit extract (150–300 mg) usually delivers 75–150 mg of mogroside V, though this varies by brand and formulation. Always check the supplement label for mogroside V percentage and total extract weight to ensure consistent dosing across products.

### Is mogroside V safe for long-term daily supplementation in humans?

While preclinical and short-term human studies suggest mogroside V is well-tolerated with minimal adverse effects, long-term safety data from controlled clinical trials in humans remains limited. Monk fruit extract containing mogroside V has been used traditionally for centuries and is classified as GRAS (Generally Recognized As Safe) by the FDA, but more extended human studies are needed to confirm safety for daily use beyond 12 weeks. Individuals with known allergies to Siraitia grosvenorii (monk fruit plant) should avoid mogroside V supplements.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*